AR025455A1 - MESOPROGESTINES (PROGESTERONE RECEPTORS MODULATORS) AS COMPONENTS OF FEMALE ANTI-CONCEPTIVES - Google Patents
MESOPROGESTINES (PROGESTERONE RECEPTORS MODULATORS) AS COMPONENTS OF FEMALE ANTI-CONCEPTIVESInfo
- Publication number
- AR025455A1 AR025455A1 ARP000104536A ARP000104536A AR025455A1 AR 025455 A1 AR025455 A1 AR 025455A1 AR P000104536 A ARP000104536 A AR P000104536A AR P000104536 A ARP000104536 A AR P000104536A AR 025455 A1 AR025455 A1 AR 025455A1
- Authority
- AR
- Argentina
- Prior art keywords
- contraception
- mesoprogestines
- conceptives
- components
- female
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Uso de mesoprogestinas para producir un producto farmacéutico para la anticoncepcion femenina, a una preparacion farmacéutica para la anticoncepcionfemenina y a un método anticonceptivo femenino que administra cantidades efectivas de unamesoprogesti na en una mujer que desea contar con anticoncepcion.Opcionalmente, la mesoprogestina puede utilizarse en combinacion con un estrogeno. Las mesoprogestinas se definen como compuestos que disponen de actividadtanto agonística comoantagonística en el r eceptor de progesterona (RP) in vivo. Estabilizan la funcion de RP en un nivel intermedio entre agonístico yantagonístico. Con las progestinas o las antiprogestinas no es posible lograr estados funcionales correspondientes.J867, J912, J956 y J1042 s on lasmesoprogestinas preferibles de acuerdo con la presente.Use of mesoprogestins to produce a pharmaceutical product for female contraception, a pharmaceutical preparation for contraception, and a female contraceptive method that administers effective amounts of unamesoprogestin in a woman who wishes to have contraception.Optionally, mesoprogestin can be used in combination with an estrogen Mesoprogestins are defined as compounds that have agonistic activity as antagonistic in the progesterone receptor (RP) in vivo. They stabilize the RP function at an intermediate level between yantagonistic agonistic. With the progestins or the antiprogestins it is not possible to achieve corresponding functional states.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38613399A | 1999-08-31 | 1999-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR025455A1 true AR025455A1 (en) | 2002-11-27 |
Family
ID=23524305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000104536A AR025455A1 (en) | 1999-08-31 | 2000-08-31 | MESOPROGESTINES (PROGESTERONE RECEPTORS MODULATORS) AS COMPONENTS OF FEMALE ANTI-CONCEPTIVES |
Country Status (28)
Country | Link |
---|---|
EP (1) | EP1605949A2 (en) |
JP (1) | JP2003511399A (en) |
KR (1) | KR20020038745A (en) |
CN (1) | CN1384748A (en) |
AR (1) | AR025455A1 (en) |
AU (1) | AU781835B2 (en) |
BG (1) | BG106441A (en) |
BR (1) | BR0013711A (en) |
CA (1) | CA2383650A1 (en) |
CO (1) | CO5190694A1 (en) |
CZ (1) | CZ2002707A3 (en) |
EA (1) | EA006805B1 (en) |
EE (1) | EE200200103A (en) |
HR (1) | HRP20020265A2 (en) |
HU (1) | HUP0202515A3 (en) |
IL (1) | IL148415A0 (en) |
LT (1) | LT5001B (en) |
LV (1) | LV12940B (en) |
MX (1) | MXPA02002186A (en) |
NO (1) | NO20020998L (en) |
NZ (1) | NZ517470A (en) |
PE (1) | PE20010579A1 (en) |
PL (1) | PL353994A1 (en) |
SI (1) | SI20853A (en) |
SK (1) | SK2982002A3 (en) |
UA (1) | UA77150C2 (en) |
WO (1) | WO2001026603A2 (en) |
YU (1) | YU13902A (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004014935A1 (en) * | 2002-08-02 | 2004-02-19 | Schering Aktiengesellschaft | Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
DE10236405A1 (en) | 2002-08-02 | 2004-02-19 | Schering Ag | New 4-(3-oxo-estra-4,9-dien-11 beta-yl)-benzaldehyde oximes, are progesterone receptor modulators useful in female contraception, hormone replacement therapy and treatment of gynecological disorders |
US7772219B2 (en) * | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
US20050215535A1 (en) * | 2004-03-24 | 2005-09-29 | Kristof Chwalisz | Sequential SPRM/progestin treatment |
PA8638601A1 (en) * | 2004-07-07 | 2006-07-03 | Wyeth Corp | CYCLE PROGESTINE REGIMES AND KITS |
DE102005050729A1 (en) * | 2005-10-19 | 2007-04-26 | Schering Ag | Method of preventive on-demand hormonal contraception |
AU2010237120B8 (en) | 2009-04-14 | 2015-11-26 | Laboratoire Hra-Pharma | Method for on-demand contraception |
CN110548034A (en) * | 2019-07-12 | 2019-12-10 | 广州莎蔓生物科技有限公司 | Pregnancy-blocking medicine |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2054271A (en) | 1932-05-17 | 1936-09-15 | Schering Kahlbaum Ag | Production of crystallized hormone esters |
DE699310C (en) | 1936-11-20 | 1940-11-27 | Chemische Ind Ges | Process for the preparation of compounds of the estradiol type which are esterified in the 3-position |
US2225419A (en) | 1937-03-01 | 1940-12-17 | Schering Corp | Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols |
US2611773A (en) | 1951-08-21 | 1952-09-23 | Upjohn Co | Estradiol 17-cyclopenetanepropionate |
US2990414A (en) | 1957-03-26 | 1961-06-27 | Syntex Sa | 17-undecenoate of estradiol |
DE3337450A1 (en) | 1983-10-12 | 1985-04-25 | Schering AG, 1000 Berlin und 4709 Bergkamen | PROSTAGLANDINE AND ANTIGESTAGE FOR PREGNANCY ABORT |
ATE209919T1 (en) * | 1987-09-24 | 2001-12-15 | Jencap Res Ltd | CONTRACEPT PACKS CONTAINING ESTROGEN AND PROGESTIN |
US5439913A (en) | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
US5516769A (en) | 1993-02-19 | 1996-05-14 | The Medical College Of Hampton Roads | Method of inhibiting fertilization |
DE4332284C2 (en) * | 1993-09-20 | 1997-05-28 | Jenapharm Gmbh | 11-Benzaldoxime-17beta-methoxy-17alpha-methoxymethyl-estradiene derivatives, process for their preparation and medicaments containing these compounds |
DE4332283A1 (en) * | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Novel 11-benzaldoximestradiene derivatives, processes for their preparation and medicaments containing these compounds |
DE4429397C2 (en) | 1994-08-09 | 2003-11-20 | Jenapharm Gmbh | Estra-1,3,5 (10) -triene derivatives, processes for their preparation and pharmaceutical compositions containing these compounds |
DE4429398C2 (en) | 1994-08-09 | 1997-09-11 | Jenapharm Gmbh | Use of Estra-1,3,5 (10) -triene derivatives for hormonal contraception |
PT787002E (en) * | 1994-10-24 | 2007-03-30 | Schering Ag | Competitive progesterone antagonists for regulating female fertility as required |
US6040340A (en) * | 1996-05-07 | 2000-03-21 | Schering Aktiengesellschaft | Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors |
AU725670B2 (en) * | 1996-06-25 | 2000-10-19 | Akzo Nobel N.V. | Progestogen-anti-progestogen regimens |
WO1998005679A2 (en) * | 1996-08-05 | 1998-02-12 | Duke University | Mixed agonists of the progesterone receptor and assays therefor |
DE19809845A1 (en) * | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituted 11beta-benzaldoxime-estra-4,9-diene-carbonic acid thiol esters, processes for their preparation and pharmaceutical preparations containing these compounds |
CA2371273A1 (en) * | 1999-05-04 | 2000-11-09 | Andrew Fensome | Tetracyclic progesterone receptor modulator compounds and methods |
-
2000
- 2000-08-31 AU AU32150/01A patent/AU781835B2/en not_active Ceased
- 2000-08-31 WO PCT/IB2000/002053 patent/WO2001026603A2/en not_active Application Discontinuation
- 2000-08-31 EA EA200200284A patent/EA006805B1/en not_active IP Right Cessation
- 2000-08-31 CO CO00065517A patent/CO5190694A1/en not_active Application Discontinuation
- 2000-08-31 AR ARP000104536A patent/AR025455A1/en unknown
- 2000-08-31 PL PL00353994A patent/PL353994A1/en not_active Application Discontinuation
- 2000-08-31 HU HU0202515A patent/HUP0202515A3/en unknown
- 2000-08-31 SK SK298-2002A patent/SK2982002A3/en unknown
- 2000-08-31 SI SI200020043A patent/SI20853A/en not_active IP Right Cessation
- 2000-08-31 CZ CZ2002707A patent/CZ2002707A3/en unknown
- 2000-08-31 JP JP2001529395A patent/JP2003511399A/en active Pending
- 2000-08-31 EE EEP200200103A patent/EE200200103A/en unknown
- 2000-08-31 MX MXPA02002186A patent/MXPA02002186A/en not_active Application Discontinuation
- 2000-08-31 NZ NZ517470A patent/NZ517470A/en unknown
- 2000-08-31 YU YU13902A patent/YU13902A/en unknown
- 2000-08-31 PE PE2000000894A patent/PE20010579A1/en not_active Application Discontinuation
- 2000-08-31 UA UA2002032429A patent/UA77150C2/en unknown
- 2000-08-31 CN CN00812308A patent/CN1384748A/en active Pending
- 2000-08-31 EP EP00991299A patent/EP1605949A2/en not_active Withdrawn
- 2000-08-31 CA CA002383650A patent/CA2383650A1/en not_active Abandoned
- 2000-08-31 KR KR1020027002785A patent/KR20020038745A/en not_active Application Discontinuation
- 2000-08-31 IL IL14841500A patent/IL148415A0/en unknown
- 2000-08-31 BR BR0013711-1A patent/BR0013711A/en not_active IP Right Cessation
-
2002
- 2002-02-26 BG BG06441A patent/BG106441A/en unknown
- 2002-02-28 NO NO20020998A patent/NO20020998L/en not_active Application Discontinuation
- 2002-03-26 LT LT2002035A patent/LT5001B/en not_active IP Right Cessation
- 2002-03-28 HR HR20020265A patent/HRP20020265A2/en not_active Application Discontinuation
- 2002-03-28 LV LVP-02-52A patent/LV12940B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL148415A0 (en) | 2002-09-12 |
JP2003511399A (en) | 2003-03-25 |
LT5001B (en) | 2003-03-25 |
NO20020998D0 (en) | 2002-02-28 |
NO20020998L (en) | 2002-03-14 |
UA77150C2 (en) | 2006-11-15 |
HRP20020265A2 (en) | 2004-02-29 |
EA006805B1 (en) | 2006-04-28 |
NZ517470A (en) | 2004-03-26 |
SK2982002A3 (en) | 2002-07-02 |
KR20020038745A (en) | 2002-05-23 |
LT2002035A (en) | 2002-10-25 |
CZ2002707A3 (en) | 2002-11-13 |
WO2001026603A2 (en) | 2001-04-19 |
WO2001026603A3 (en) | 2002-01-17 |
SI20853A (en) | 2002-10-31 |
EE200200103A (en) | 2003-04-15 |
EA200200284A1 (en) | 2002-10-31 |
BR0013711A (en) | 2002-05-07 |
CO5190694A1 (en) | 2002-08-29 |
BG106441A (en) | 2002-09-30 |
CA2383650A1 (en) | 2001-04-19 |
HUP0202515A2 (en) | 2002-12-28 |
HUP0202515A3 (en) | 2004-06-28 |
EP1605949A2 (en) | 2005-12-21 |
YU13902A (en) | 2006-01-16 |
LV12940B (en) | 2003-06-20 |
AU3215001A (en) | 2001-04-23 |
CN1384748A (en) | 2002-12-11 |
AU781835B2 (en) | 2005-06-16 |
PL353994A1 (en) | 2003-12-15 |
MXPA02002186A (en) | 2002-09-02 |
PE20010579A1 (en) | 2001-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2256365A1 (en) | Compositions, methods and devices for the transdermal delivery of drugs | |
PT836506E (en) | TRANSDERMAL PENSION FOR ADMINISTRATION OF 17-DECACEACY NORGESTIMATE SO OR IN COMBINATION WITH A ESTROGEN | |
WO2006053172A3 (en) | The use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune diseases | |
PT87053A (en) | METHOD FOR THE PREPARATION OF CONTRACEPTIVE COMPOSITIONS CONTAINING MELETONIN AND METHOD FOR CONDUCTING CONTRACEPTION | |
PE20051038A1 (en) | EXTENDED COMBINATION USE INCLUDING ESTROGENS AND PROGESTINES | |
EP1260206A3 (en) | Pants-type disposable wearing article | |
NO20024908D0 (en) | 8 <beta> -hydrocarbyl-substituted estrogens for use as selective estrogens | |
ATE288744T1 (en) | MEDICINAL FORMULATIONS FOR HORMONE REPLACEMENT THERAPY FOR TOPICAL USE ON THE SKIN | |
AR035904A1 (en) | 5- [2-HIDROXI-3-1- (3-TRIFLUOROMETILFENIL) -CICLOPROPIL-PROPIONILAMINO] -FTALIDA AND COMPOUNDS RELATED TO PROGESTERONE RECEPTOR MODULAR ACTIVITY | |
AR025455A1 (en) | MESOPROGESTINES (PROGESTERONE RECEPTORS MODULATORS) AS COMPONENTS OF FEMALE ANTI-CONCEPTIVES | |
EA200100108A1 (en) | APPLICATION OF BIOGENAL SULFAMATS OF ESTROGENS FOR HORMONE-SUBSTITUTE THERAPY | |
EA200900451A1 (en) | METHOD OF OBTAINING COMPOSITION OF ESTRADIOL WITH SLOW-BREAKDOWN (OPTIONS), ESTRADIOL AND CHOLESTEROL MICROSPHERE AND METHOD FOR SIMULTANEOUS CONTRACEPTION AND HORSE SUBSTITUTION | |
ES2162900T3 (en) | L-N-MENTOL LIQUID COMPOSITION AND PROCEDURE FOR PREPARATION. | |
BR0214634A (en) | Steroid hormone-containing transdermal therapeutic systems containing propylene glycol monocaprylate | |
CR10289A (en) | "STRATRIENS 9-ALFA-SUBSTITUTED AS SELECTIVE EFFECTIVENESS STROGENS" (DIVISIONAL) | |
AR033160A1 (en) | ABSORBENT PRODUCT | |
AR025456A1 (en) | MESOPROGESTINES (PROGESTERONE RECEIVER MODULATORS) AS COMPONENTS OF COMPOSITIONS USED FOR HORMONAL REPLACEMENT THERAPY (HRT) | |
CN201019886Y (en) | Field operations fast fixing upper limb combination equipment | |
BR0214334A (en) | Method for providing a topical base composition for use in the preparation of a cosmetic composition, resealable cosmetic container, and anhydrous composition | |
AR033835A1 (en) | A PRODUCT FOR PERSONAL HYGIENE SUCH AS A PAD FOR WOMEN'S HYGIENE | |
DE10250470A1 (en) | Hygiene product for men and boys, absorbs residual urine discharge and other secretions | |
CN2452478Y (en) | Bandage for hip | |
KR970005295A (en) | Vaginal tablets containing bamboo salt and mica as active ingredients | |
ATE546144T1 (en) | USE OF ESTRADIOLVALERATE IN COMBINATION WITH DIENOGEST FOR ORAL THERAPY OF DYSF UNCTIONAL UTERINE BLEEDING IN UNIT WITH ORAL CONTRACEPTION | |
BR0010070A (en) | Use of org 33245, contraceptive kit, combined means for the measurement of a progestin and an antiprogestogen, and methods of contraception, and for treatment of irregular uterine bleeding or rupture in a female using a progestin-only preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |